Publicaciones en colaboración con investigadores/as de Southampton General Hospital (21)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  2. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

    European Journal of Preventive Cardiology, Vol. 29, Núm. 4, pp. 645-653

2021

  1. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

    Leukemia, Vol. 35, Núm. 10, pp. 2885-2894

  2. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  3. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  4. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  5. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: An international cohort study

    BMJ Open, Vol. 11, Núm. 11

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

  2. Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation

    Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380

2012

  1. Home parenteral nutrition: An international benchmarking exercise

    e-SPEN Journal, Vol. 7, Núm. 5

  2. Randomized phase III study comparing paclitaxel/cisplatin/ gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987

    Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1107-1113

2008

  1. Aliskiren - The first of a new class of antihypertensive

    Drugs in Context, Vol. 4, Núm. 1, pp. 105-120

  2. Cervarix - Preventing cervical cancer and other diseases related to HPV

    Drugs in Context, Vol. 4, Núm. 1, pp. 59-70

  3. Coversyl Plus - Treating hypertension and improving clinical outcomes in T2D and other high risk groups

    Drugs in Context, Vol. 4, Núm. 1, pp. 71-84

  4. Ezetimibe - A clinically effective and a cost-effective treatment option for dyslipidaemia

    Drugs in Context, Vol. 4, Núm. 1, pp. 85-104

  5. Gardasil - Preventing cervical cancer and other diseases related to HPV

    Drugs in Context, Vol. 4, Núm. 1, pp. 29-40

  6. Inegy - Effective combination treatment to target LDL-C levels

    Drugs in Context, Vol. 4, Núm. 1, pp. 41-58

  7. Telmisartan - An effective antihypertensive for 24-hour blood pressure control

    Drugs in Context, Vol. 4, Núm. 1, pp. 1-14

  8. Tiotropium - Advancing the treatment of COPD

    Drugs in Context, Vol. 4, Núm. 1, pp. 15-28